Skip to content
Tolerx, Inc. logo

Tolerx, Inc. Alternatives & Competitors

12 companies similar to Tolerx, Inc.

Companies similar to Tolerx, Inc.

Novelogics Biotechnology Inc. logo — alternative to Tolerx, Inc.

Novelogics Biotechnology Inc.

Pre-clinical stage biotech company developing an antibody immunotherapy drug for cancer us...

ImmunoCellular Therapeutics Ltd logo — alternative to Tolerx, Inc.

ImmunoCellular Therapeutics Ltd

Pioneering immune-based therapies to harness the body's defenses against cancer through ad...

VBL Therapeutics (Nasdaq:VBLT) logo — alternative to Tolerx, Inc.

VBL Therapeutics (Nasdaq:VBLT)

Engineering the future of targeted medicines, breaking barriers to develop the next genera...

Q32 Bio Inc. logo — alternative to Tolerx, Inc.

Q32 Bio Inc.

Revolutionizing the future of targeted immune therapeutics

Rival Readout

Competing with Tolerx, Inc.? We do this properly.

10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.

Book a 7-day Readout
Coley Pharmaceutical Group logo — alternative to Tolerx, Inc.

Coley Pharmaceutical Group

Empowering the immune system to conquer illnesses and boost vaccine efficacy.

Prescient Therapeutics logo — alternative to Tolerx, Inc.

Prescient Therapeutics

A clinical stage oncology company developing personalised medicine approaches to cancer; c...

Algiax Pharmaceuticals logo — alternative to Tolerx, Inc.

Algiax Pharmaceuticals

Disarming chronic neuropathic pain

Revitope logo — alternative to Tolerx, Inc.

Revitope

Powered for Precision: Revolutionizing immunotherapy to safely and effectively treat more...

Memgen, Inc. logo — alternative to Tolerx, Inc.

Memgen, Inc.

Memgen's Vision: Develop Life-Saving Cancer Immunotherapies

Abintus Bio, Inc. logo — alternative to Tolerx, Inc.

Abintus Bio, Inc.

Empowering patients from within

RemAb Therapeutics logo — alternative to Tolerx, Inc.

RemAb Therapeutics

Removing harmful antibodies.

Elicio Therapeutics logo — alternative to Tolerx, Inc.

Elicio Therapeutics

Lymph-Node Targeted Immunotherapies

About Tolerx, Inc.

Tolerx, Inc. is a trailblazer in immunology, with a remarkable array of pioneering drug candidates designed to combat not only type 1 diabetes, but also a range of autoimmune disorders and cancer by restoring balance to immune responses. The company's lineup features otelixizumab, its primary candidate in Phase 3 devel...

Business keywords

Cancer Treatment, Diabetes Treatment, Autoimmune Disease, Immunotherapy, T Cell Immunotherapy, Drug Development, Clinical Trials, Immune Response Modulation, Antibody Treatment, Pharmaceuticals, Preclinical Candidates, Immune System Regulation, Viral Infections, Immune System Disorders

Frequently Asked Questions

Companies similar to Tolerx, Inc. include Novelogics Biotechnology Inc., ImmunoCellular Therapeutics Ltd, VBL Therapeutics (Nasdaq:VBLT), Q32 Bio Inc., Coley Pharmaceutical Group. They work in Biotechnology and Health Care and share Tolerx, Inc.'s focus on immunotherapy, drug development and cancer treatment.
Bounce Watch lists 12 companies that share Tolerx, Inc.'s industries and are closest to it in business tags, services, target customers, business model and size.
Tolerx, Inc. is a trailblazer in immunology, with a remarkable array of pioneering drug candidates designed to combat not only type 1 diabetes, but also a range of autoimmune disorders and cancer by restoring balance to immune responses. The company's lineup features otelixizumab, its primary candidate in Phase 3 devel...

From the desk

Mapping a market? Start with a Rival Readout.

In 7 business days we read 10 rivals around Tolerx, Inc.: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.

Compiled from the BounceWatch company index. We last looked at Tolerx, Inc. on 12 Sep 2024. The 12 companies listed here were last checked between 21 Jun 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout